5-ALPHA-REDUCTASE INHIBITORS IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

被引：0
|
作者：
Dai, Charles
Ganesan, Vishnu
Zabell, Joseph
Nyame, Yaw
Hettel, Daniel
Almassi, Nima
Greene, Daniel
Haywood, Samuel
Reichard, Chad
Zampini, Anna
Crane, Alice
Arora, Hans
El-Shafei, Ahmed
Stein, Robert
Fareed, Khaled
Gong, Michael
Jones, J. Stephen
Stephenson, Andrew
Klein, Eric
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2819
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD08-03
引用
收藏
页码：E229 / E229
页数：1
相关论文
共 50 条
  • [1] Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer
    Chiang, Andrew S.
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (11-12): : 450 - 453
  • [2] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    Finelli, A.
    Komisarenko, M.
    Martin, L. J.
    Timilshina, N.
    Jain, K.
    Morris, J.
    Zlotta, A.
    Kulkarni, G.
    Perlis, N.
    van der Kwast, T.
    Evans, A.
    Ghai, S.
    Fleshner, N.
    Alibhai, S. M. H.
    Hamilton, R. J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 69 - 76
  • [3] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    A. Finelli
    M. Komisarenko
    L. J. Martin
    N. Timilshina
    K. Jain
    J. Morris
    A. Zlotta
    G. Kulkarni
    N. Perlis
    T. van der Kwast
    A. Evans
    S. Ghai
    N. Fleshner
    S. M. H. Alibhai
    R. J. Hamilton
    [J]. Prostate Cancer and Prostatic Diseases, 2021, 24 : 69 - 76
  • [4] The role of 5-alpha-reductase inhibitors in active surveillance
    Margel, David
    Fleshner, Neil
    [J]. CURRENT OPINION IN UROLOGY, 2012, 22 (03) : 243 - 246
  • [5] Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer
    Chiang, Andrew Szehsun
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [6] 5-alpha-reductase inhibitors for prostate cancer prevention
    不详
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (06) : 553 - 553
  • [7] The use of 5-alpha-reductase inhibitors for the prevention of prostate cancer
    Yu, Eun-mi
    El-Ayass, Walid
    Aragon-Ching, Jeanny B.
    [J]. CANCER BIOLOGY & THERAPY, 2010, 10 (01) : 11 - 12
  • [8] Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer
    Finelli, Antonio
    Trottier, Greg
    Lawrentschuk, Nathan
    Sowerby, Robert
    Zlotta, Alexandre R.
    Radomski, Lenny
    Timilshina, Narhari
    Evans, Andrew
    van der Kwast, Theodorus H.
    Toi, Ants
    Jewett, Micheal A. S.
    Trachtenberg, John
    Fleshner, Neil E.
    [J]. EUROPEAN UROLOGY, 2011, 59 (04) : 509 - 514
  • [9] PROSTATE EFFECTS OF 5-ALPHA-REDUCTASE INHIBITORS
    RASMUSSON, GH
    REYNOLDS, GF
    STEINBERG, NG
    PATEL, GF
    WALTON, E
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 193 : 8 - MEDI
  • [10] 5-Alpha-reductase inhibitors in diseases of the prostate
    Carrasquillo, Robert J.
    Nealy, Sean W.
    Wang, David S.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (06) : 488 - 492
12345